TSG Advice Partners LLC acquired a new stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 6,170 shares of the biopharmaceutical company’s stock, valued at approximately $920,000. Several other […]
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.